Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of NRD101 in Patients with Knee Osteoarthritis
jRCT2080223476Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Mar 2017
- Countries
- 2
01
Overview
Phase 3, randomised trial of hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Started Mar 2017; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2080223476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223476.